![]() |
Volumn 370, Issue 17, 2014, Pages 1664-1665
|
Romosozumab in Postmenopausal Women with Osteopenia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ROMOSOZUMAB;
SCLEROSTIN;
BONE DENSITY CONSERVATION AGENT;
MONOCLONAL ANTIBODY;
DICKKOPF 1 PROTEIN;
ADVERSE OUTCOME;
BONE;
BONE DENSITY;
CARDIOVASCULAR EFFECT;
DRUG EFFECT;
DRUG SAFETY;
DRUG THERAPY;
HIGH RISK POPULATION;
HUMAN;
LETTER;
MORTALITY;
OSTEOPENIA;
POSTMENOPAUSE;
PRIORITY JOURNAL;
VASCULAR TISSUE;
BONE REMODELING;
FEMALE;
NOTE;
POSTMENOPAUSE OSTEOPOROSIS;
BLOOD VESSEL CALCIFICATION;
CARDIOVASCULAR RISK;
DISEASE ASSOCIATION;
KIDNEY FAILURE;
PATHOGENESIS;
PHASE 3 CLINICAL TRIAL (TOPIC);
PROTEIN BLOOD LEVEL;
PROTEIN FUNCTION;
ANTIBODIES, MONOCLONAL;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
BONE REMODELING;
FEMALE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
|
EID: 84899102042
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1402396 Document Type: Letter |
Times cited : (37)
|
References (5)
|